Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_provenance.
- NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_assertion wasGeneratedBy ECO_0000203 NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_provenance.
- NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_assertion wasDerivedFrom befree-20140225 NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_provenance.
- NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_assertion SIO_000772 21898529 NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_provenance.
- NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_assertion evidence source_evidence_literature NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_provenance.
- NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_assertion description "[Therefore, we propose that CTA-specific immunotherapy for AML should preferentially target PRAME and/or should be combined with the application of demethylating agents opening the perspective for alternative targets like CTA SSX-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP298558.RAsvfyQgHJgDaq7Hxg7iP7Nn1kalvvfS54PB6F8mqq6u8130_provenance.